WHO ICTRP trial
A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of…
NL-OMON52110 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON52110 |
|---|---|
| Public title | A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX study |
| Scientific title | A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX study - PARADOX study |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | IBD ulcerative colitis;10017969;ulcerative colitis |
| Interventions | Patients take place in a hyperbaric chamber pressurized to 2.4-2.5 atmosphere absolute (243-253 kPA), while breathing 100% oxygen through a mask for 80 minutes. Including 5-minute air breaks, the total procedure lasts 110 minutes. Subjects… |
| Registration date | Jul 22, 2022 |
| Target size | 24 |
| Secondary IDs | 2021-003913-21;NL78575.018.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: